The size of the Asia-Pacific open MRI Systems Market was worth USD 0.59 Billion in 2021 and is expected to reach USD 0.93 Billion by 2026, growing at a CAGR of 9.40% from 2021 to 2026.
MRI is a scan that utilizes the magnetic field and pulses from Radio wave energy to make pictures of internal parts of our body. MRI may show problems that weren’t seen by other imaging methods. MRIs are generally closed, but some don’t enclose your body completely, which is called open MRI. But they aren’t available everywhere.
MRI is mainly used for finding problems like tumors, injury, Bleeding, Blood Vessel Diseases, or Infection. It is also used to see a problem encountered on an x-ray or CT scan. MRI can take pictures of the Head, Spine, Brain, Abdominal, cardiac, and blood vessels and find the diseases or any problems associated with them. In the past, open MRI was considered a low field MRI, and most people think it’s less powerful than closed MRI. But now a day’s field strength is increased and in the range of midfield MRI. Its field strength is even improved to the high field, but we do not call it open anymore.
There are many drivers in this market, like an increase in MRI techniques, an aging population, Developing Markets, software Applications, open architecture, and the development of MRI-compatible pacemakers. But some of the factors like draining helium gas deposits, high cost of MRI systems, declining reimbursement rates, the complexity of machines, and lack of skilled labor are restraining the market. This is the fastest-growing region globally because of the developing market and the increase in spending limits of people.
This research report on the Asia Pacific Open MRI Systems Market segmented and sub-segmented into the following categories.
By Field Strength:
By Application:
By Country:
Companies playing a notable role in the Asia-Pacific Open MRI Systems market profiled in the report are Hitachi Medical Corporation (Japan), Toshiba Medical Systems (Japan), Siemens Healthcare (Germany), GE Healthcare (U.K.), and Philips Healthcare (Netherlands).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Field Strength
5.1.1 Introduction
5.1.2 Low to Mid field
5.1.3 Y-o-Y Growth Analysis, By Field Strength
5.1.4 Market Attractiveness Analysis, By Field Strength
5.1.5 Market Share Analysis, By Field Strength
5.2 Application
5.2.1 Introduction
5.2.2 Brain
5.2.3 Spine
5.2.4 Abdominal
5.2.5 Breast
5.2.6 Cardiac
5.2.7 Y-o-Y Growth Analysis, By Application
5.2.8 Market Attractiveness Analysis, By Application
5.2.9 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Field Strength
6.1.3.3 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Field Strength
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Field Strength
6.1.5.3 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Hitachi Medical Corporation
8.3 Philips Healthcare
8.4 Siemens Healthcare
8.5 Toshiba Medical Systems
8.6 Aastrom Biosciences
8.7 Celgene Corporation
8.8 Invitrogen
8.9 Cytori Therapeutics
8.10 Retractable Technologies
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
